Rare diseases
Investigational molecules
Locations
Back to Poland45 clinical trials in Chrzanow, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
PolandEfficacy and Safety of REGN7508, REGN9933, and Rivaroxaban in Adults with Peripheral Artery Disease after Recent Lower‑Extremity Revascularization
PolandStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
PolandA Study of Encoberminogene Rezmadenovec Gene Therapy for Patients with Refractory Angina Due to Coronary Artery Disease
PolandStudy on the Effects of T89 and Glyceryl Trinitrate for Patients with Stable Angina
PolandA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
PolandA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
PolandA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
PolandStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
PolandStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
PolandStudy on Dabigatran and Ticagrelor for Patients with Acute Coronary Syndrome and Atrial Fibrillation Undergoing Heart Procedure
PolandStudy on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels
PolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on heart failure treatment and prevention, including studies of innovative therapies like baxdrostat and dapagliflozin combinations. Research encompasses both acute and chronic conditions.
Multiple studies are evaluating novel approaches to reduce major cardiovascular events and improve patient outcomes.
Clinical investigations targeting chronic obstructive pulmonary disease and severe viral lung infections, with emphasis on testing new therapeutic agents like tezepelumab and tozorakimab.
Research focuses on improving breathing function and reducing disease exacerbations.
Advanced research in chronic kidney disease treatment, including combination therapy trials and studies on preventing surgery-associated kidney injury.
Studies aim to slow disease progression and improve outcomes in patients with kidney conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
